13F-HR filed by Tri Locum Partners LP
Tri Locum Partners LP filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 18 holding rows worth $435,052,388.
- Accession
- 0001826434-25-000008
- Filer
- CIK 1826434
- Filed
- 2025-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2025
A holdings report, 18 entries on the cover page, a total value of $435,052,388 stated on the cover page (in dollars after the unit check, H1), rows summing to $435,052,388 with VALUE read as dollars as filed, 13F file number 028-21000. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Johnson & Johnson | 478160104 | COM | 302,831 | $56,150,924 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 122,187 | $51,222,012 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 446,874 | $37,506,135 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 292,137 | $35,480,039 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 174,829 | $34,757,753 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 1,190,207 | $34,587,415 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 43,411 | $32,018,217 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 67,706 | $31,054,034 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 450,585 | $30,459,546 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 89,621 | $20,750,846 | dollars as filed | |
| KORRO BIO INC | 500946108 | COMMON STOCK | 337,764 | $16,175,518 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 366,102 | $14,698,995 | dollars as filed | |
| AVADEL PHARMACEUTICALS PLC | G29687103 | COM SHS | 724,859 | $11,068,597 | dollars as filed | |
| STEVANATO GROUP S P A ORD SHS | T9224W109 | Stock | 332,912 | $8,572,484 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 182,867 | $7,195,816 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 119,260 | $7,087,622 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 75,986 | $4,027,258 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 149,179 | $2,239,177 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001826434-25-000008 | this filing | 2025-11-14 | acceptance time not in the bulk data set |